Inhibition of pseudo-allergic reactions by vitamin K3 directly targeting GAB1 in mast cells
International Immunopharmacology · 2024
DOI: 10.1016/j.intimp.2024.112490 ↗Kurz gefasst
Fachartikel in der Zeitschrift International Immunopharmacology, 2024. Verfasst von Mengyang Ma und 7 weiteren Autor:innen. Beteiligte Einrichtung: School of Pharmacy, Xi'an Jiaotong University, Xi'an, China. Hauptthemen laut MEDLINE: Mast Cells, Adaptor Proteins, Signal Transducing. Die Arbeit nennt 47 Literaturangaben. Gefördert von: National Natural Science Foundation of China.
Abstract (Originalsprache)
BACKGROUND: Vitamin K3 (VK3), a fat-soluble synthetic analog of the vitamin K family, has coagulant, anti-inflammatory, antibacterial, and anticancer properties. Pseudo allergy is a IgE-independent immune response associated with mast cells. This study investigated the role of VK3 in IgE-independent mast cell activation. METHODS: Substance P (SP) was used to induce LAD2-cell activation in order to analyze the effects of VK3 in vitro. Cutaneous allergy and systemic allergy mouse models were used to analyze the anti-pseudo-allergic effects of VK3. Proteome microarray assays were used to analyze VK3-binding protein. Biolayer interferometry and immunoprecipitation were used to verify interaction between VK3 and its key targets. RNA interference was used to determine the role of GAB1 in LAD2cell activation. RESULTS: VK3 inhibited SP-induced LAD2-cell activation, and resulted in the release of β-hexosaminidase, histamine and cytokines; VK3 inhibited SP-induced pseudo allergic reactions in mice, and serum histamine and TNF-α levels decreased. Degranulation of skin mast cells was reduced; GAB1 in mast cells was stably bound to VK3. GAB1 participated in SP-induced LAD2-cell activation. GAB1 knockdown in LAD2 cells prevented SP-induced β-hexosaminidase release, calcium mobilization and cell skeletal remodeling. VK3 directly binds to GAB1 and reduces its expression to inhibited SP-induced LAD2 cell activation. CONCLUSION: The anti-pseudo-allergic activity of VK3 was confirmed in vitro and in vivo. VK3 can inhibit SP-induced mast cell activation by directly targeting GAB1. This study provides new insights on the activity of VK3 and the mechanism of pseudoallergic reaction.
Schlagwörter
MeSH-Schlagwörter (MEDLINE)
Stichwörter der Autor:innen
Substanzen
Autor:innen und Institutionen
- School of Pharmacy, Xi'an Jiaotong University, Xi'an, China.
- The First Affiliated Hospital of Xi'an Jiaotong University, Xi'an, China.
- School of Pharmacy, Xi'an Jiaotong University, Xi'an, China. Electronic address: wangnan2014@xjtu.edu.cn.
Förderung
- National Natural Science Foundation of China
Zitieren
APA
Ma, M., Xue, Z., Li, C., Zhang, X., Gao, J., Deng, T., Gao, C., & Wang, N. (2024). Inhibition of pseudo-allergic reactions by vitamin K3 directly targeting GAB1 in mast cells. International Immunopharmacology. https://doi.org/10.1016/j.intimp.2024.112490
Vancouver
Ma M, Xue Z, Li C, Zhang X, Gao J, Deng T, et al. Inhibition of pseudo-allergic reactions by vitamin K3 directly targeting GAB1 in mast cells. International Immunopharmacology. 2024. doi:10.1016/j.intimp.2024.112490
BibTeX
@article{Ma2024,
author = {Ma, Mengyang and Xue, Zhuoyin and Li, Chenjia and Zhang, Xinping and Gao, Jie and Deng, Tingting and Gao, Chang and Wang, Nan},
title = {Inhibition of pseudo-allergic reactions by vitamin K3 directly targeting GAB1 in mast cells},
journal = {International Immunopharmacology},
year = {2024},
doi = {10.1016/j.intimp.2024.112490}
}
EUVIMED